361/1507US=23-D / Câncer
Kanematsu M, Semelka RC, Osada S. Expression of hepatocellular endothelial growth factor in hepatocellular carcinoma: correlation with radiologic findings. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 193-211. ISBN 978-1-4020-9803-1.

HISTORIA DE DIAGNOSTICO RADIOLOGICO DO CARCINOMA HEPATOCELULAR; DESENVOLVIMENTO DE CARCINOMA HEPATOCELULAR


362/1507US=23-D / Câncer
Kiryu S, Ohtomo K. Detection of small hepatic lesion: superparamagnetic oxide-enhanced diffusion-Weighted T2 FSE imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 213-9. ISBN 978-1-4020-9803-1.

LESAO HEPATICA PEQUENA; SUPERPARAMAGNETICO OXIDO AVANCADA DIFUSAO PONDERADA T2 FSE IMAGEM; SPIO AVANCADA DWI T2 FSE IMAGEM USANDO HELICE


363/1507US=23-D / Câncer
Onishi H, Murakami T, Nakumura H. Diagnosis of hepatocellular carcinoma: multidetector-row computed tomography and magnetic resonance imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 221-35. ISBN 978-1-4020-9803-1.

TECNICA DE VARREDURA POR RESSONANCIA MAGNETICA; CONTRASTE DINAMICO MAIOR RESSONANCIA MAGNETICA; COMPUTADOR ANGIOTOMOGRAFIA; RESSONANCIA MAGNETICA DE CARCINOMA HEPATOCELULAR; ESTADIAMENTO DO CARCINOMA HEPATOCELULAR


364/1507US=23-D / Câncer
Ichikawa T, Araki T. Hepatocellular carcinoma: effects of injection rate/injection duration of contrast material on computer tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 237-40. ISBN 978-1-4020-9803-1.

CARCINOMA HEPATOCELULAR. EFEITOS DA DURACAO INJECAO TAXA; INJECCAO DE MATERIAL DE CONTRASTE EM TOMOGRAFIA COMPUTADORIZADA


365/1507US=23-D / Câncer
Nishie A, Yoshimitsu K. Detection of combined hepatocellular and cholangiocarcinoma: enhanced computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 241-60. ISBN 978-1-4020-9803-1.

DETECCAO DE COLANGIOCARCINOMA HEPATOCELULAR E COMBINADO; TOMOGRAFIA COMPUTADORIZADA


366/1507US=23-D / Câncer
Takayasu K. Hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules): and a combination of computer tomography and angiography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 241-60. ISBN 978-1-4020-9803-1.

LESOES NODULARES HEPATOCELULARES; HEPATOCARCINOGENESE; AGULHA DE BIOPSIA; CARCINOMA HEPATOCELULAR AVANCO; CARCINOMA HEPATOCELULAR PRECOCE; CARCINOMA HEPATOCELULAR NODULO; HIPO-ATENUANTES LESOES NODULARES


367/1507US=23-D / Câncer
Lodato F, Davies N, Yu D, Burroughs AK. Hepatocellular cancer in cirrhotic patients: radiological imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 261-73. ISBN 978-1-4020-9803-1.

TOMOGRAFIA COMPUTADORIZADA HELICOIDAL; PROBLEMAS DE PEQUENOS NODULOS


368/1507US=23-D / Câncer
Hsu C, Chen CN, Cheng AL. Treatment of hepatocellular carcinoma with thalidomide: assessment with power doppler ultrasound. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 277-86. ISBN 978-1-4020-9803-1.

TRATAMENTO DO CARCINOMA HEPATOCELULAR COM TALIDOMIDA; VASCULARIZACAO DO TUMOR. ULTRASSOM DOPPLER


369/1507US=23-D / Câncer
Denecke T, Hildebrandt B, Lopez-Hänninen E. Perfusion scintigraphy with integrated single photon emission computed tomography / computed tomography in the management of transarterial treatment of hepatic malignancies. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 287-301. ISBN 978-1-4020-9803-1.

CINTILOGRAFIA DE PERFUSAO COM EMISSAO DE FOTON UNICO; TOMOGRAFIA COMPUTADORIZADA; DOENCAS MALIGNAS HEPATICAS TRANSARTERIAL. TRATAMENTO; QUIMIOTERAPIA ARTERIAL HEPATICA; RADIOEMBOLIZACAO


370/1507US=23-D / Câncer
Sun HC. Postoperative interferon alpha treatment of patients with hepatocellular carcinoma: expression of p48 using tissue microarray. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 303-10. ISBN 978-1-4020-9803-1.

TRATAMENTO POS-OPERATORIO INTERFERON ALFA. PACIENTES COM CARCINOMA HEPATOCELULAR; P48 USANDO TISSUE MICROARRAY


371/1507US=23-D / Câncer
Ng KTP, Man K. Hepatocellular carcinoma: overexpression of homeoprotein six 1 as a marker for predicting surgical. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 313-23. ISBN 978-1-4020-9803-1.

CARCINOMA HEPATOCELULAR


372/1507US=23-D / Câncer
Schmid K, Mosberger I, Wrba F. Hepatocellular carcinoma: KiSS-1 overexpression as a prognostic factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 325-31. ISBN 978-1-4020-9803-1.

CARCINOMA HEPATOCELULAR; KISS-1 SUPEREXPRESSAO COMO FATOR PROGNOSTICO


373/1507US=23-D / Câncer
Nakamura H, Yoshida K, Tomita Y. Hepatocellular carcinoma: prognosis using hepatoma-derived growth factor immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 333-42. ISBN 978-1-4020-9803-1.

CARCINOMA HEPATOCELULAR; HEPATOMA. FATOR DE CRESCIMENTO DERIVADO; METODOS DE IMUNO-HISTOQUIMICA; ANALITICA; HEPATOMA DERIVADO. EVOLUCAO


374/1507US=23-D / Câncer
Kuramitsu Y, Nakamura K,. Hepatitis C virus-related human hepatocellular carcinoma: predictive markers using proteomic analysis (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 343-50. ISBN 978-1-4020-9803-1.

VIRUS DA HEPATITE C X CARCINOMA HEPATOCELULAR HUMANO; PROTEOMICA; PROTEOMICA PARA TECIDOS DE CARCINOMA HEPATOCELULAR; PROTEOMICA PARA SOROS FROW PACIENTES COM CARCINOMA HEPATOCELULAR; PROTEOMICA PARA VIRUS DA HEPATITE C TECIDOS RELACIONADOS HEPATOCELULARES


375/1507US=23-D / Câncer
Rafaelsen SR. Liver metastases from colorectal cancer: ultrasound imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 355-67. ISBN 978-1-4020-9803-1.

METASTASES HEPATICAS DE CANCER COLORRETAL


376/1507US=23-D / Câncer
Graham KC, Wirtzfeld LA, Lacefield JC, Chambers AF. Preclinical liver metastases: three-dimensional high-frequency ultrasound imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 369-86. ISBN 978-1-4020-9803-1.

METASTASES HEPATICAS


377/1507US=23-D / Câncer
Truant S, Huglo D, Pruvot FR. Colorectal liver metastases: 18F-fluorodeoxyglucose-positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 387-406. ISBN 978-1-4020-9803-1.

METASTASES HEPATICAS COLORRETAIS; 18F-FLUORO-TOMOGRAFIA POR EMISSAO DE POSITRONS


378/1507US=23-D / Câncer
Nakanuma Y, Ikeda H, Sato Y, Harada K, Nakamura K, Zen Y. Biliary cystic tumors: clinicopathological features. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 411-28. ISBN 978-1-4020-9803-1.

BILIARES TUMORES CISTICOS


379/1507US=23-D / Câncer
Inui K, Mioyshi H, Yoshino J. Cholangiocarcinoma: intraductal sonography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 429-37. ISBN 978-1-4020-9803-1.

COLANGIOCARCINOMA


380/1507US=23-D / Câncer
Zaika AI, Hong SM. Extrahepatic bile duct carcinoma: role of the p53 protein family. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 441-9. ISBN 978-1-4020-9803-1.

EXTRA-HEPATICO CARCINOMA DO DUCTO BILIAR; PROTEINA P53


Primeira | Anterior | Próxima | Última